Results 51 to 60 of about 555,884 (236)

A multi-country survey on access to healthcare and treatment services among individuals with critical medical care needs during the first wave of the pandemic

open access: yesBMC Public Health, 2023
Background Healthcare services were significantly interrupted during the early phase of the COVID-19 pandemic. The aim of the present study was to determine the associations between sociodemographic factors and healthcare access during the first wave of ...
Morenike Oluwatoyin Folayan   +15 more
doaj   +1 more source

Focusing on quality patient care in the new global subsidy for malaria medicines. [PDF]

open access: yes, 2009
Tido von Schoen-Angerer and colleagues discuss the new Affordable Medicines Facility for malaria (AMFm), which subsidizes and facilitates access to artemisinin-based combination therapy, and what mechanisms are needed to ensure it stays focused on ...
Moon, S   +4 more
core   +2 more sources

Review of medicine registration system in Tanzania [PDF]

open access: yes, 2019
Philosophiae Doctor - PhDRegistration of medicines is an essential function of the national medicine regulatory system of any country. Since the start of the medicine registration system in Tanzania in early 2000s, no systematic review has been carried
KISOMA, SUNDAY
core   +3 more sources

Developing an intuitive decision support system for equitable vaccine distribution during pandemics

open access: yesScientific Reports
Effective organization of the vaccine supply chain is vital to achieve high vaccination rates in pandemics. This paper presents a novel approach for developing a decision support system (DSS) to support health officials and policymakers who must make ...
Lise Boey   +9 more
doaj   +1 more source

Associations of mental disorders and neurotropic parasitic diseases: a meta-analysis in developing and emerging countries

open access: yesBMC Public Health, 2019
Background Although they are declining worldwide, neurotropic parasitic diseases are still common in developing and emerging countries. The aim of this study was to estimate the pooled prevalence and pooled association measures of comorbidities between ...
Labanté Outcha Daré   +6 more
doaj   +1 more source

Judicialization of access to medicines in four Latin American countries: a comparative qualitative analysis

open access: yesInternational Journal for Equity in Health, 2019
Background The valuation of medicines as health needs vary depending on the stakeholders involved (users, prescribers, managers, etc.) and their expectations. These factors modulate the role of medicines as a health need and influence access to medicines,
Claudia Marcela Vargas-Pelaez   +12 more
doaj   +1 more source

“‘It is very difficult in this business if you want to have a good conscience’: pharmaceutical governance and on-the-ground ethical labor in Ghana”: a letter to editors

open access: yesGlobal Bioethics, 2023
Establishing effective pharmaceutical governance is a challenge for government agencies, private enterprises, and professionals working on the ground, demanding complex ethical decisions from the actors involved, especially in a lower-middle-income ...
Livia Maria de Souza Gonçalves   +4 more
doaj   +1 more source

Submission to the United Nations Secretary General's High Level Panel on Access to Medicines [PDF]

open access: yes, 2016
Much of the current debate on health care goals, medical innovation and trade rules focuses on the misalignment between the need to provide incentives to innovation – mainly through a tight intellectual property (IPR) regime – and the resulting negative ...
Kale, Dinar   +3 more
core  

Challenge and co-operation: civil society activism for access to HIV treatment in Thailand. [PDF]

open access: yes, 2009
Civil society has been a driving force behind efforts to increase access to treatment in Thailand. A focus on HIV medicines brought civil society and non-governmental and government actors together to fight for a single cause, creating a platform for ...
Ainsworth   +30 more
core   +2 more sources

A PRSZT Registry Analysis of Prognostic Factors Influencing Survival and Relapse Rates After Second Allogeneic Hematopoietic Stem Cell Transplantation in Pediatric Acute Lymphoblastic Leukemia

open access: yesPediatric Blood &Cancer, EarlyView.
ABSTRACT A second allogeneic (allo‐)hematopoietic stem cell transplantation (HSCT2) is a potential curative option for pediatric patients with acute lymphoblastic leukemia (ALL) following relapse after first allogeneic transplantation (HSCT1), but its efficacy is limited by high relapse rates and transplant‐related toxicity in highly pretreated ...
Ava Momm   +10 more
wiley   +1 more source

Home - About - Disclaimer - Privacy